secwatch / observer
8-K filed October 2, 2024, 7:59 PM ET ticker CLYM CIK 0001768446
other material confidence high sentiment neutral materiality 0.40

Eliem Therapeutics renames to Climb Bio, ticker changes to CLYM on Nasdaq

Climb Bio, Inc.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Climb Bio, Inc.: Amended and restated bylaws solely to reflect the name change (effective 2024-10-02).

Change
bylaw amendment
Effective
2024-10-02
Exact text from the filing
the Board also approved an amendment and restatement of the Company’s Amended and Restated Bylaws solely to reflect the Name Change (as amended and restated, the “Amended and Restated Bylaws”) effective as of October 2, 2024.
View on SEC.gov
Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Climb Bio, Inc.: Amended certificate of incorporation to change company name from Eliem Therapeutics, Inc. to Climb Bio, Inc (effective 2024-10-02).

Change
charter amendment
Effective
2024-10-02
Exact text from the filing
Effective as of 4:00 p.m., Eastern Time on October 2, 2024, Eliem Therapeutics, Inc. (the “Company”) amended its Amended and Restated Certificate of Incorporation (the “Certificate of Incorporation”), to effect a change of the Company’s name from “Eliem Therapeutics, Inc.” to “Climb Bio, Inc.”
View on SEC.gov

89 governance changes filed in the last 30 days. Browse all governance changes →

Climb Bio, Inc. filing history →

Source: SEC EDGAR
accession 0001193125-24-231167
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.